Robert Lafyatis

26.5k total citations · 7 hit papers
236 papers, 14.2k citations indexed

About

Robert Lafyatis is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Immunology. According to data from OpenAlex, Robert Lafyatis has authored 236 papers receiving a total of 14.2k indexed citations (citations by other indexed papers that have themselves been cited), including 129 papers in Pathology and Forensic Medicine, 91 papers in Molecular Biology and 60 papers in Immunology. Recurrent topics in Robert Lafyatis's work include Systemic Sclerosis and Related Diseases (126 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (40 papers) and Connective Tissue Growth Factor Research (20 papers). Robert Lafyatis is often cited by papers focused on Systemic Sclerosis and Related Diseases (126 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (40 papers) and Connective Tissue Growth Factor Research (20 papers). Robert Lafyatis collaborates with scholars based in United States, China and Netherlands. Robert Lafyatis's co-authors include Tracy Tabib, Michael B. Sporn, Raphaël Lemaire, Anita B. Roberts, Michael L. Whitfield, Giuseppina Farina, Wei Chen, R L Wilder, Elaine F. Remmers and Michael York and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nucleic Acids Research.

In The Last Decade

Robert Lafyatis

230 papers receiving 14.0k citations

Hit Papers

Proliferating SPP1/MERTK-expressing macrophages in idio... 2015 2026 2018 2022 2019 2020 2019 2019 2015 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Lafyatis United States 66 5.3k 4.6k 4.1k 2.9k 2.1k 236 14.2k
Hironobu Ihn Japan 58 4.5k 0.9× 4.1k 0.9× 2.2k 0.5× 1.8k 0.6× 1.9k 0.9× 384 11.8k
Kazuhiko Takehara Japan 69 4.3k 0.8× 6.8k 1.5× 3.8k 0.9× 2.5k 0.9× 1.4k 0.7× 375 15.9k
Maria Trojanowska United States 61 4.6k 0.9× 4.0k 0.9× 1.7k 0.4× 1.7k 0.6× 952 0.5× 171 10.0k
Marvin J. Fritzler Canada 64 6.0k 1.1× 5.6k 1.2× 4.5k 1.1× 2.0k 0.7× 682 0.3× 410 18.6k
Andrew Leask Canada 63 8.7k 1.6× 3.0k 0.7× 1.3k 0.3× 2.1k 0.7× 1.2k 0.6× 230 14.7k
Tadashi Yoshino Japan 54 2.4k 0.5× 4.4k 1.0× 2.7k 0.7× 1.2k 0.4× 3.5k 1.7× 524 12.6k
Ritsuro Suzuki Japan 59 2.1k 0.4× 5.4k 1.2× 3.2k 0.8× 1.7k 0.6× 5.3k 2.5× 381 13.2k
Renate E. Gay Switzerland 65 5.5k 1.0× 1.9k 0.4× 3.5k 0.9× 1.2k 0.4× 2.1k 1.0× 174 13.4k
Jochen Zwerina Austria 64 4.9k 0.9× 1.6k 0.4× 2.3k 0.6× 1.8k 0.6× 2.0k 1.0× 229 12.2k
Maurilio Ponzoni Italy 65 4.7k 0.9× 6.6k 1.4× 3.8k 0.9× 973 0.3× 6.6k 3.1× 296 16.6k

Countries citing papers authored by Robert Lafyatis

Since Specialization
Citations

This map shows the geographic impact of Robert Lafyatis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Lafyatis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Lafyatis more than expected).

Fields of papers citing papers by Robert Lafyatis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Lafyatis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Lafyatis. The network helps show where Robert Lafyatis may publish in the future.

Co-authorship network of co-authors of Robert Lafyatis

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Lafyatis. A scholar is included among the top collaborators of Robert Lafyatis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Lafyatis. Robert Lafyatis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yablonska, Svitlana, Peng Xi, Duah Alkam, et al.. (2025). IP-to-MS: An Unbiased Workflow for Antigen Profiling. Journal of Proteome Research. 24(2). 795–812.
3.
Padilla, Cristina M., et al.. (2025). Effects of Audio‐Guided Imagery on Raynaud Phenomenon in Connective Tissue Disease. ACR Open Rheumatology. 7(8). e70074–e70074.
4.
Shehabeldin, Mostafa, Jin Gao, Rong Chong, et al.. (2024). Local Controlled Delivery of IL-4 Decreases Inflammatory Bone Loss in a Murine Model of Periodontal Disease. The Journal of Immunology. 213(11). 1635–1643. 6 indexed citations
5.
Tabib, Tracy, Hanxi Xiao, Dinesh Khanna, et al.. (2023). Cell Type–Specific Biomarkers of Systemic Sclerosis Disease Severity Capture Cell‐Intrinsic and Cell‐Extrinsic Circuits. Arthritis & Rheumatology. 75(10). 1819–1830. 8 indexed citations
6.
Tabib, Tracy, et al.. (2023). Single-Cell Transcriptome Analysis Identifies Subclusters with Inflammatory Fibroblast Responses in Localized Scleroderma. International Journal of Molecular Sciences. 24(12). 9796–9796. 28 indexed citations
7.
Wang, Xinjun, Zhongli Xu, Haoran Hu, et al.. (2022). SECANT: a biology-guided semi-supervised method for clustering, classification, and annotation of single-cell multi-omics. PNAS Nexus. 1(4). pgac165–pgac165. 1 indexed citations
8.
Bulik, Melissa, Travis Lear, Yanwen Chen, et al.. (2022). Fibronectin-EDA accumulates via reduced ubiquitination downstream of Toll-like receptor 9 activation in SSc-ILD fibroblasts. American Journal of Physiology-Lung Cellular and Molecular Physiology. 323(4). L484–L494. 5 indexed citations
9.
Hamburg‐Shields, Emily, John P. Lydon, Ying Yan, et al.. (2021). Skin Fibrosis and Recovery Is Dependent on Wnt Activation via DPP4. Journal of Investigative Dermatology. 142(6). 1597–1606.e9. 25 indexed citations
10.
Spiera, Robert, Laura K. Hummers, Leland W.K. Chung, et al.. (2020). Safety and Efficacy of Lenabasum in a Phase II, Randomized, Placebo‐Controlled Trial in Adults With Systemic Sclerosis. Arthritis & Rheumatology. 72(8). 1350–1360. 72 indexed citations
11.
Chakraborty, Debomita, Honglin Zhu, Astrid Jüngel, et al.. (2020). Fibroblast growth factor receptor 3 activates a network of profibrotic signaling pathways to promote fibrosis in systemic sclerosis. Science Translational Medicine. 12(563). 36 indexed citations
12.
Tabib, Tracy, Xinjun Wang, Wei Chen, et al.. (2020). Single-cell transcriptome conservation in a comparative analysis of fresh and cryopreserved human skin tissue: pilot in localized scleroderma. Arthritis Research & Therapy. 22(1). 101–101. 31 indexed citations
13.
Saygın, Didem, Tracy Tabib, Humberto E. Trejo Bittar, et al.. (2020). Transcriptional profiling of lung cell populations in idiopathic pulmonary arterial hypertension. Pulmonary Circulation. 10(1). 1–15. 67 indexed citations
14.
Tabib, Tracy, et al.. (2019). Single-Cell Lymphocyte Heterogeneity in Advanced Cutaneous T-cell Lymphoma Skin Tumors. Clinical Cancer Research. 25(14). 4443–4454. 85 indexed citations
15.
Moll, Matthew, Romy Christmann, Yuqing Zhang, et al.. (2018). Patients with systemic sclerosis-associated pulmonary arterial hypertension express a genomic signature distinct from patients with interstitial lung disease. Journal of Scleroderma and Related Disorders. 3(3). 242–248. 11 indexed citations
16.
Christmann, Romy, Percival D. Sampaio‐Barros, Carlos Roberto Ribeiro de Carvalho, et al.. (2016). miR-155 in the progression of lung fibrosis in systemic sclerosis. Arthritis Research & Therapy. 18(1). 155–155. 85 indexed citations
17.
Bhattacharyya, Swati, Kathleen Kelley, Denisa S. Melichian, et al.. (2012). Toll-Like Receptor 4 Signaling Augments Transforming Growth Factor-β Responses. American Journal Of Pathology. 182(1). 192–205. 209 indexed citations
18.
Radstake, Timothy R. D. J., Lenny van Bon, Jasper Broen, et al.. (2009). Increased Frequency and Compromised Function of T Regulatory Cells in Systemic Sclerosis (SSc) Is Related to a Diminished CD69 and TGFβ Expression. PLoS ONE. 4(6). e5981–e5981. 131 indexed citations
19.
Lafyatis, Robert & Michael York. (2009). Innate immunity and inflammation in systemic sclerosis. Current Opinion in Rheumatology. 21(6). 617–622. 60 indexed citations
20.
Horan, Gerald, Susan Wood, Victor Ona, et al.. (2007). Partial Inhibition of Integrin αvβ6 Prevents Pulmonary Fibrosis without Exacerbating Inflammation. American Journal of Respiratory and Critical Care Medicine. 177(1). 56–65. 331 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026